Hepatotoxicity after short-term trazodone therapy

Annals of Pharmacotherapy

Volumn 35, Issue 12, 2001, Pages 1559-1561

  Rettman, Kristina S ^a,b   McClintock, Claudia ^c  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Hepatitis; Trazodone

Indexed keywords

CLONIDINE; DIDANOSINE; LIVER ENZYME; METHADONE; NEVIRAPINE; STAVUDINE; TRAZODONE;

ADULT; ARTICLE; CASE REPORT; CHOLESTASIS; COMORBIDITY; DETOXIFICATION; DOSE RESPONSE; DRUG DEPENDENCE TREATMENT; DRUG WITHDRAWAL; HEPATITIS C; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COMORBIDITY; FEMALE; HEPATITIS, TOXIC; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS; TRAZODONE;

EID: 0035668364     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10406     Document Type: Article

References (7)

1. Trazodone and liver toxicity
2. Trazodone and intrahepatic cholestasis
3. Trazodone-induced hepatotoxicity and leukonychia
4. Trazodone-induced hepatotoxicity: A case report with comments on drug-induced hepatotoxicity
5. Chronic active hepatitis associated with trazodone therapy
6. A method for estimating the probability of adverse drug reactions
7. Oral administration of clonidine in patients with alcoholic cirrhosis: Hemodynamic and liver function effects